APA (7th ed.) Citation

XH, N., WT, W., R, A., S, G., J, Z., & CL, W. (2025). Do AR and TILs have any association with the efficacy of neoadjuvant treatment for HER2-positive breast cancer? Medicine, 104(36), e44364. https://doi.org/10.1097/MD.0000000000044364

Chicago Style (17th ed.) Citation

XH, Ni, Wang WT, An R, Gao S, Zhang J, and Wang CL. "Do AR and TILs Have Any Association with the Efficacy of Neoadjuvant Treatment for HER2-positive Breast Cancer?" Medicine 104, no. 36 (2025): e44364. https://doi.org/10.1097/MD.0000000000044364.

MLA (9th ed.) Citation

XH, Ni, et al. "Do AR and TILs Have Any Association with the Efficacy of Neoadjuvant Treatment for HER2-positive Breast Cancer?" Medicine, vol. 104, no. 36, 2025, p. e44364, https://doi.org/10.1097/MD.0000000000044364.